Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment

Effective antiviral therapy plays a key role in slowing the progression of chronic hepatitis B (CHB). Identification of serum indices, including hepatitis B e antigen (HBeAg) expression and seroconversion, will facilitate evaluation of the efficacy of antiviral therapy in HBeAg-positive CHB patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiezuan, Yan, Dong, Guo, Renyong, Chen, Jiajia, Li, Yongtao, Fan, Jun, Fu, Xuyan, Yao, Xinsheng, Diao, Hongyan, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348167/
https://www.ncbi.nlm.nih.gov/pubmed/28272219
http://dx.doi.org/10.1097/MD.0000000000006242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348167/
https://www.ncbi.nlm.nih.gov/pubmed/28272219
http://dx.doi.org/10.1097/MD.0000000000006242

Ejemplares similares